Adenocarcinoma - GEJ
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric (NCT05315830) | The First Affiliated Hospital of Bengbu Medical University | 2022-03-07 |
| Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer (NCT04984733) | University of Southampton | 2021-09-28 |
| DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) (NCT04014075) | Daiichi Sankyo | 2019-11-26 |
Track Adenocarcinoma - GEJ automatically
Every clearance here is in the API, with alerts when new ones post.